Información del producto
Erastin2 is a lipid-based gene therapy agent that is designed to inhibit the production of fatty acids. It binds with high affinity to enzymes involved in fatty acid synthesis and inhibits their activity, reducing the levels of fatty acid metabolites. Erastin2 has been shown to induce necrotic cell death in cancer cells and reduce body weight in obese mice. This drug has also been shown to induce autophagy, which is a process by which cells degrade themselves through apoptosis when nutrient availability is low. Erastin2 induces autophagy by activating AMPK (adenosine monophosphate kinase), which activates transcriptional regulation of genes involved in the autophagy pathway.
Propiedades químicas
Consulta técnica sobre: 3D-VSC53344 Erastin2
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
